期刊文献+

普萘洛尔对映异构体的血浆样品测定

The Determination of Propranolol Enantiomers in Plasma
原文传递
导出
摘要 建立以2,3,4,6-四乙酰基-β—D-吡喃葡萄糖基异硫氰酸酯(GITC)为手性衍生化试剂测定血浆中普萘洛尔对映体浓度的反相高效液相色谱方法。血浆样品经甲醇除蛋白。采用C18色谱柱(4.61mm×250mm,5μm,Bnentnach),流动相为甲醇-20mmol/LKH2P04的水溶液(75:25);流速ImL/min;检测波长220nm。结果:S(-)-普萘洛尔和尺(+)-普萘洛尔检测浓度在1.00-277.78pg/mL浓度范围内与色谱峰面积有良好的线性关系。日内、日间精密度均小于5%,回收率分别为98.95%和105.76%,RSD均小于7.13%。结论:本方法灵敏度高,重现性可用于血浆中普萘洛尔对映体的分离测定。 The purpose is to establish a RP- HPLC method with the chiral derivatization reagent 2,3,4,6 - tetra- D- acety-β-D - glucopy- ranosyl- isothiocyanate for separating and detemaining the propranolol enantiomers in plasma. The proteill in plasma samples were was removed with methanol The RP- HPLC separation of propranolol enantiomers was carried out on a C18 column(4. 6 mm× 250 mm, 5 μm. The mobile phase consisted of methanol - 20mmol/LKH2PO4 and aqueous solution(75 : 25). The flow rate was lml/min. The detection wavelength was 220 nm. The linear range was 1.00-277. 78μg/ml. The intra- and inter- day precision was both less than 5%. The recovery was 98. 95%o and 105. 76%, respectively and the RSD was less than 7. 13% The method is sensitive and was a good repeatability for the separation and determination of propranolol enantionmers in plasma.
出处 《药物生物技术》 CAS CSCD 2011年第4期336-338,共3页 Pharmaceutical Biotechnology
关键词 普萘洛尔 手性 反相高效液相色谱 血浆 Propranolol Chiral RP- HPLC Plasma
  • 相关文献

参考文献9

二级参考文献20

  • 1沙先谊,方晓玲,吴云娟.9-硝基喜树碱在Caco-2细胞模型中的体外摄取、转运及外排动力学[J].药学学报,2004,39(10):839-843. 被引量:21
  • 2周权 姚彤炜 曾苏.Chiral drug interaction [J].Chinese Pharmaceutica Sinica(中国药学杂志),1999,34(11):721-724.
  • 3Alex D. Chiralily--A cause for panie[J]. Chemistry in Britain, 1988, 24(9): 847-848.
  • 4Yoshio O, Mitsunobu K, Koichi H. Useful chiral packing material for high-performance liquid chromatographic resolution of enantioners: Phenylcarbamates of polysaccharides coated on silica gel[J]. J Am Chem Soc, 1984,106(18) : 5357-5359.
  • 5Pettersson C,Schill G.Separation of enanticmers in ionpair chromatographic systems[J].J Liq Chromatogr,1986,9(2):269—290.
  • 6杨青,药学学报,1988年,23卷,921页
  • 7王晓鸣,国外医学药学分册,1987年,14卷,280页
  • 8Brown JR,Collett JH,Attwood D,et al.lntluence of moncaprinon the penn eability of a diacidic drug BTA-243 across Caco-2 cell monlayers and everted gut csc[J]. Int J Pharm, 2002; 245 ( 1-2 ) : 133- 142.
  • 9Artursson P.Cell cultures as models for drug absorption across the intestinalmucosa[J]. Crit.Riv.Ther.Drug Carrier Syst, 1991 ; 8(5 ) : 305- 330.
  • 10Tavelin S,Grasjo F,Tainpalensuu J,et al.Applieations fepithelial cell culture in studics of drug transport[J]. Methods MolBiol,2002; 188(8) :233-272.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部